JCR Pharmaceuticals Co.,Ltd. (4552)

Market cap
¥73B
P/E ratio
42.9x
JCR Pharma develops and manufactures pharmaceutical and regenerative medicine products for healthcare providers worldwide, with specialized focus on advanced regenerative treatments.
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 2025-38.4-187.08%
Mar 31, 202444.1+45.40%
Mar 31, 202330.4-74.12%
Mar 31, 2022117.3+110.11%
Mar 31, 202155.8-35.77%
Mar 31, 202086.9-28.00%
Mar 31, 2019120.7+22.23%
Mar 31, 201898.7+67.48%
Mar 31, 201759+5.04%
Mar 31, 201656.1+6.19%
Mar 31, 201552.9+29.57%
Mar 31, 201440.8+77.12%
Mar 31, 201323+16.61%
Mar 31, 201219.8
AI Chat